Introduction
- Business Opportunities with Ranbaxy: Core Competencies
Ranbaxy Pharmaceuticals Inc. (RPI) has already experienced commercial
success penetrating the U.S. health care market, and is looking
to enhance growth and future business opportunities through
collaboration and strategic alliances.
Ranbaxy Pharmaceuticals Inc. (RPI) is a product-driven pharmaceutical
company with diversified expertise. As a wholly owned subsidiary
of Ranbaxy Laboratories Limited, India’s largest pharmaceutical
company, RPI offers an advantage of having a global presence
with experience in more than 125 international markets.
The company’s advanced product development and manufacturing
capabilities, combined with a global sales and marketing network,
make RPI an attractive business partner. A key part of RPI’s
business strategy is to collaborate with partners with complementary
skills – a mutually beneficial strategy for both parties.
API Development and Production
Ranbaxy can provide Active Pharmaceutical Ingredients (API)
for companies that want to manufacture their own product or
brand without incurring the time and costs associated with developing
the API, eliminating this step from the overall manufacturing
process. Key advantages of using Ranbaxy's vertically integrated
system are:
 |
Continuity of supply |
|
|
Consistent quality of product |
|
Competitive costs |
|
Flexibility and resources to respond to changing market
dynamics |
Dosage Form Development and Manufacturing
Ranbaxy's experience as a global manufacturer makes it an ideal
partner to take on the complex process of solid or liquid dosage
form development. Ranbaxy continually uses reverse engineering
to improve upon its development and manufacturing processes
and enhance yield, with a focus on achieving greater cost efficiencies.
Contract Manufacturing
To expand product lines with minimum investment, Ranbaxy provides
turnkey manufacturing services, including API and dosage form
development, to allow companies to focus on marketing and selling
the product. This is an efficient way to diversify product lines
and increase profit margins, taking advantage of Ranbaxy's manufacturing
capabilities and expertise.
Sales and Marketing
Ranbaxy has set itself apart in the marketplace through the
rapid expansion of its product line and its willingness to emulate
complex drug formulations. RPI's commitment to quickly expanding
the breadth and depth of its product line has been key to its
success in the marketplace.
Ranbaxy has a commercial advantage as many of the high-profit
branded drugs with expiring patents over the next few years
are in the categories where Ranbaxy has proven expertise - anti-infectives,
gastrointestinal, cardiovascular and analgesics.
RPI has a turnkey marketing group that works with other pharmaceutical
companies to co-market and co-promote a variety of chemicals
and products. As a marketing partner, RPI is able to meet the
marketing needs of companies while they themselves focus their
efforts on a drug's development, manufacturing, distribution
and sales.
Marketing Strategies
Marketing Strategies is the department focused primarily on
developing and executing strategies for the promotion and distribution
of branded, generic and OTC products for RPI.
One of the key tasks for the department is to identify opportunities
in different markets and distribution channels and pursue those
to developing and establish new relationships in the marketplace.
Managed Care and Internet marketing are a couple of key areas
that the department is looking to introduce into its ever-expanding
service offerings.
Licensing
RPI prides itself on taking a creative, mutually beneficial
approach to licensing arrangements. The company is open to exploring
both outward and inward licensing opportunities to fulfill unmet
needs in the marketplace.
|
